Access Statistics for James Mason

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Evaluating change in professional behaviour: issues in design and analysis 0 0 0 33 0 1 8 201
NICEly does it: economic analysis within evidence-based clinical practice guidelines 0 0 0 30 0 0 8 177
Optometrist prescribing of therapeutic agents: economic implications for the UK 0 0 1 42 0 1 6 263
Screening for diabetic retinopathy by optometrists: effectiveness and cost-effectiveness 0 0 0 66 0 0 8 423
The DH register of cost-effectiveness studies: a review of study content and quality 0 0 0 28 0 0 2 112
Topical preparations for the treatment of psoriasis in primary care: a systematic review 0 0 0 37 0 0 7 334
Total Working Papers 0 0 1 236 0 2 39 1,510


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A framework for incorporating cost-effectiveness in evidence-based clinical practice guidelines 0 0 0 8 2 2 11 50
Agreement between gastrointestinal panel testing and standard microbiology methods for detecting pathogens in suspected infectious gastroenteritis: Test evaluation and meta-analysis in the absence of a reference standard 0 0 0 1 0 0 2 8
Biotechnology: a special case for health technology assessment? 0 0 0 8 0 0 4 40
Compassionate containment? Balancing technical safety and therapy in the design of psychiatric wards 0 0 0 0 1 1 4 33
Correction to: Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal 0 0 0 0 0 0 3 15
Cost-effectiveness league tables: More harm than good? 0 0 1 64 0 1 10 155
Cost-effectiveness league tables: think of the fans 0 0 0 17 1 1 6 62
Creating ‘therapeutic landscapes’ for mental health carers in inpatient settings: A dynamic perspective on permeability and inclusivity 0 0 0 2 1 1 3 30
Methodological Issues Surrounding the Use of Baseline Health-Related Quality of Life Data to Inform Trial-Based Economic Evaluations of Interventions Within Emergency and Critical Care Settings: A Systematic Literature Review 0 0 0 0 1 1 5 22
Multivariate Generalized Linear Mixed-Effects Models for the Analysis of Clinical Trial–Based Cost-Effectiveness Data 0 0 0 2 0 1 7 18
Optometrist prescribing of therapeutic agents: findings of the AESOP survey 0 0 0 13 0 0 0 50
Prophylactic Antibiotics to Prevent Cellulitis of the Leg: Economic Analysis of the PATCH I & II Trials 0 0 0 0 1 1 7 10
Reporting guidelines for economic studies 0 0 0 0 1 2 12 15
Spaces for smoking in a psychiatric hospital: Social capital, resistance to control, and significance for ‘therapeutic landscapes’ 0 0 0 0 0 0 3 21
Student corner 0 0 0 0 1 2 5 11
The Importance of Achieving Additional Drug Benefits at a Reasonable Cost 0 0 0 3 0 0 7 73
The urgent case for stronger climate targets for international shipping 0 0 0 4 0 0 6 22
Venetoclax for Treating Chronic Lymphocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal 0 0 0 0 1 1 6 18
Total Journal Articles 0 0 1 122 10 14 101 653


Statistics updated 2026-08-07